As reported by the National Health Executive, the new funding will accelerate projects in advanced drug production and treatments targeting antibiotic resistance
The UK’s life sciences sector is set for a fresh wave of innovation after ministers confirmed more than £74 million in new public and private investment. Officials said the funding will help strengthen a £150 billion-a-year industry that employs over 300,000 people nationwide.
The announcement, made during London Life Sciences Week, comes as the UK seeks to reinforce its status as Europe’s leading hub for biotech and medical research. Recent data shows London companies secured £1.6 billion in venture capital this year – over three times the total raised in Paris.
A large share of the money, £54 million, will support eight projects within the Sustainable Medicines Manufacturing Innovation Programme. The initiatives aim to cut waste and speed up production by using AI and robotics, capture and reuse anaesthetic gases to save NHS costs, explore methods of transforming spent nuclear material into advanced cancer therapies, and develop bacteriophage-based treatments to counter antibiotic resistance.
Regulators will also receive close to £1 million to help shape the rules around bacteriophage therapies, an emerging technology that experts say could become vital as antibiotic resistance grows.
Be the first to comment